|
Oct 1
|
Novocure to Report Third Quarter 2024 Financial Results
|
|
Sep 6
|
Why NovoCure Stock Dived by 13% This Week
|
|
Sep 3
|
NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor
|
|
Sep 3
|
Novocure Announces Planned CEO Transition
|
|
Aug 28
|
Novocure to Participate in 2024 Wells Fargo Healthcare Conference
|
|
Aug 16
|
Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet
|
|
Aug 14
|
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
|
|
Aug 12
|
Biotech stocks: Which drugmakers are worth a buy?
|
|
Jul 25
|
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
|
|
Jul 25
|
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 25
|
NovoCure: Q2 Earnings Snapshot
|
|
Jul 25
|
Novocure Reports Second Quarter 2024 Financial Results
|
|
May 3
|
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
|
|
May 3
|
NovoCure (NVCR) Q1 2024 Earnings Call Transcript
|
|
May 2
|
NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
|
|
May 2
|
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
|
|
May 2
|
Novocure Reports First Quarter 2024 Financial Results
|
|
Apr 25
|
NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Apr 24
|
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
|